Combined exposure to agriculture pesticides, paraquat and maneb, induces alterations in the N/OFQ-NOPr and PDYN/KOPr systems in rats: Relevance to sporadic Parkinson's disease

Environmental Toxicology

Volumn 30, Issue 6, 2015, Pages 656-663

  Bastías Candia, Sussy ^a   Di Benedetto, Manuela ^b   D'Addario, Claudio ^c   Candeletti, Sanzio ^b   Romualdi, Patrizia ^b  

^a UNIVERSIDAD DE TARAPACÁ   (Chile)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF TERAMO   (Italy)

Author keywords

N OFQ NOPr system; Parkinson's disease; PDYN KOPr system; Pesticides

Indexed keywords

AGRICULTURAL CHEMICALS; AGRICULTURE; AMINO ACIDS; DISEASES; FUNGICIDES; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENES; HERBICIDES; PESTICIDES; TELECOMMUNICATION SERVICES;

COMMERCIAL AVAILABILITY; ENVIRONMENTAL FACTORS; GENE EXPRESSION LEVELS; LESS DEVELOPED COUNTRIES; NEURODEGENERATIVE DISORDERS; PARKINSON'S DISEASE; PDYN-KOPR SYSTEM; RATE-LIMITING ENZYMES;

NEURODEGENERATIVE DISEASES;

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DYNORPHIN; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; MANEB; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NOCICEPTIN; NOCICEPTIN RECEPTOR; PARAQUAT; PRODYNORPHIN; TYROSINE 3 MONOOXYGENASE; ENKEPHALIN; FUNGICIDE; HERBICIDE; OPIATE PEPTIDE; OPIATE RECEPTOR; PREPROENKEPHALIN; PROTEIN PRECURSOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPAMINE METABOLISM; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; ENZYME BLOOD LEVEL; IMMUNOREACTIVITY; LOCOMOTION; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION; WEIGHT REDUCTION; AGRICULTURE; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; GENE EXPRESSION; METABOLISM; SPRAGUE DAWLEY RAT; SUBSTANTIA NIGRA;

ANIMALIA; RATTUS;

AGRICULTURE; ANIMALS; DOWN-REGULATION; ENKEPHALINS; FUNGICIDES, INDUSTRIAL; GENE EXPRESSION; HERBICIDES; MALE; MANEB; OPIOID PEPTIDES; PARAQUAT; PARKINSON DISEASE, SECONDARY; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 84929516259     PISSN: 15204081     EISSN: 15227278     Source Type: Journal    
DOI: 10.1002/tox.21943     Document Type: Article

References (37)

1. Bäckman CM, Shan L, Zhang Y, Hoffer BJ, Tomac AC. 2007. Alterations in prodynorphin, proenkephalin, and GAD67 mRNA levels in the aged human putamen: Correlation with Parkinson's disease. J Neurosci Res 85:798-804.
2. Candeletti S, Ferri S. 2000. Effects of an antisense oligonucleotide to pronociceptin and long-term prevention of morphine actions by nociceptin. Peptides 21:1119-1124.
3. Carta AR, Fenu S, Morelli M. 2001. Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson's disease. Neurol Sci 22:59-60.
4. Carta AR, Pinna A, Tronci E, Morelli M. 2003. Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats. Neurology 61:S39-S43.
5. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
6. Cicchetti F, Lapointe N, Roberge-Tremblay A, Saint-Pierre M, Jimenez L, Ficke BW, Gross RE. 2005. Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats. Neurobiol Dis 20:360-371.
7. +and 6-OHDA lesioned rats. Neuropharmacology 56:761-767.
8. Finkbeiner S, Tavazoie SF, Maloratsky A, Jacobs KM, Harris KM, Greenberg ME. 1997. CREB: A major mediator of neuronal neurotrophin responses. Neuron 19:1031-1047.
9. Flau K, Redmer A, Liedtke S, Kathmann M, Schlicker E. 2002. Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors. Br J Pharmacol 137:1355-1361.
10. Gibb WR, Lees AJ. 1991. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry 54:388-396.
11. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ. 1998. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 50:1346-1350.
12. Haber SN, Watson SJ. 1985. The comparative distribution of enkephalin, dynorphin and substance P in the human globus pallidus and basal forebrain. Neuroscience 14:1011-1024.
13. Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mallory M, Wong J, Takenouchi T, Hashimoto M, Masliah E. 2000. Alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 157:401-410.
14. Kanda S, Bishop JF, Eglitis MA, Yang Y, Mouradian MM. 2000. Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation. Neuroscience 97:279-284.
15. Ko L, Mehta ND, Farrer M, Easson C, Hussey J, Yen S, Hardy J, Yen SH. 2000. Sensitization of neuronal cells to oxidative stress with mutated human alpha-synuclein. J Neurochem 75:2546-2554.
16. Langston JW, Ballard PA Jr. 1983. Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine. N Engl J Med 5:310.
17. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
18. Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA. 2002. The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: Paraquat and alpha-synuclein. J Biol Chem 277:1641-1644.
19. Mansour A, Khachaturian H, Lewis M.E, Akil H, Watson SJ. 1987. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 7:2445-2464.
20. Marti M, Mela F, Bianchi C, Beani L, Morari M. 2002. Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: Opposite role for D1 and D2 receptors. J Neurochem 83:635-644.
21. Marti M, Mela F, Veronesi C, Guerrini R, Salvadori S, Federici M, Mercuri NB, Rizzi A, Franchi G, Beani L, Bianchi C, Morari M. 2004. Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior. J Neurosci 24:6659-6666.
22. Marti M, Mela F, Fantin M, Zucchini S, Brown JM, Witta J, Di Benedetto M, Buzas B, Reinscheid RK, Salvadori S, Guerrini R, Romualdi P, Candeletti S, Simonato M, Cox BM, Morari M. 2005. Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease. J Neurosci 95:9591-9601.
23. Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG. 1998. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 352:1344-1346.
24. Murphy NP, Maidment NT. 1999. Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis. J Neurochem 73:179-186.
25. Norton CS, Neal CR, Kumar S, Akil H, Watson SJ. 2002. Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems. J Comp Neurol 444:358-368.
26. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
27. Saint-Pierre M, Tremblay M, Sik A, Gross R, Cicchetti F. 2006. Temporal effects of paraquat/maneb on microglial activation and dopamine neuronal loss in older rats. J Neurochem 98:760-777.
28. Schlicker E, Morari M. 2000. Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system. Peptides 21:1023-1029.
29. Shimizu K, Matsubara K, Ohtaki K, Shiono H. 2003. Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture. Neurosci Res 46:523-532.
30. Steiner H, Gerfen CR. 1998. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp Brain Res 123:60-76.
31. Takahashi RN, Rogerio R, Zanin M. 1989. Maneb enhances MPTP neurotoxicity in mice. Res Commun Chem Pathol Pharmacol 66:167-170.
32. Thiruchelvam M, Brockel B, Richifield E, Baggs R, Cory-Slechta D. 2000a. Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: Environmental risk factors for Parkinson's disease? Brain Res 873:225-234.
33. Thiruchelvam M, Richfield E, Baggs R, Tank A, Cory-Slechta D. 2000b. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: Implications for Parkinson's disease. J Neurosci 15:9207-9214.
34. Ungerstedt U. 1968. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 5:107-110.
35. Vaccari A, Saba P, Mocci I, Ruiu S. 1999. Dithiocarbamate pesticides affect glutamate transport in brain synaptic vesicles. J Pharmacol Exp Ther 288:1-5.
36. Viaro R, Sanchez-Pernaute R, Marti M, Trapella C, Isacson O, Morari M. 2008. Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonism. Neurobiol Dis 30:430-438.
37. Visanji NP, De Bie RM, Johnston TH, McCreary AC, Brotchie JM, Fox SH. 2008. The nociceptin/orphanin FQ (NOP) receptor antagonist J-113397 enhances the effects of levodopa in the MPTP-lesioned nonhuman primate model of Parkinson's disease. Mov Disord 23:1922-1925.